Balanced Portfolio Recommendation: Trim Short Nasdaq (SNAS)
The Nasdaq hedge is unlikely to work over the short-term as the thesis of the rate hiking cycle being finished, combined with the 70% occurrence of a “Christmas Rally”
Balanced Portfolio
Strategy Update: Agriculture Reporting Season – GrainCorp Earnings Update
GrainCorp’s FY23 earnings showcased robust performance with an EBITDA of $565 million, strong international demand, record FFO results, and strategic UMG stake liquidation.
Balanced Portfolio Recommendation: Add – Nufarm (NUF) 2%
Agricultural Earnings Season Update 13/11/2023
Strategy Update: Agriculture Reporting Season – Elders Earnings Update
Elders have reported results this morning beating expectations and rallying 10%. This positivity
Balanced Portfolio Recommendation: Trim Neuren Pharmaceuticals (NEU)
At all time highs, we recommend a trim of 1% (one third) of the holding
Strategy Update: Agriculture Reporting Season Update
The Biden administration has flagged $79bl as a point where the US will top up their strategic reserves, we see crude oil here at $77 good value and risk/reward
Balanced Portfolio Recommendation: Trim Neuren Pharmaceuticals (NEU)
After much higher than expected sales results, we recommend a trim of 1% (one quarter) of the holding
Balanced Portfolio Recommendation: BUY – Paladin Energy (PDN)
Recent earnings results from Canadian uranium-fuel giant, Cameco saw a significant increase in nuclear energy demand and a potential supply gap in the immediate future. This demand is driven by global calls for clean, secure, and affordable energy with Nuclear being the stop-gap solution for base load electricity until new energy technologies become more commercial
Balanced Portfolio Recommendation: Buy – Macquarie Group Ltd (MQG)
Macquarie Bank is set to announce earnings, consistently demonstrating a remarkable record of exceeding expectations. MQG is a cornerstone in our portfolios, showcasing reliable performance. We advise purchasing a 2%-4% allocation of MQG shares on Thursday, anticipating a potential gap-up at Friday’s market open, following the release of positive updates.
Balanced Portfolio Recommendation: Trim Blackrock Mining (BKT)
After a 56% rally on China banning exports to foreign countries, Ex-China graphite assets have enjoyed a spike in prices over the last few days
Balanced Portfolio Recommendation: Buy – CSL Ltd (CSL)
CSL is also very close to trial results for a heart attack drug CSL112, a key pipeline product for CSL. Base case assumptions imply a valuation of around $30/share.